TLC Taiwan Liposome Company, Ltd. - ADRs

Taiwan Liposome Co Ltd is a clinical-stage specialty pharmaceutical company. It mainly focuses on the development and commercialization of novel nanomedicines. This is an ADR of a company whose stock trades outside of the U.S. as the symbol TG:4152.

$5.97  -0.02 (-0.33%)
As of 06/14/2021 15:53:40 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Taiwan
Country of incorporation:  
IPO date:  11/21/2018
Outstanding shares:  42,077,450
Average volume:  1,035,505
Market cap:   $244,469,984
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    874038102
ISIN:        US8740381020
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.07
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy